Atherosclerosis Technologies of Personalized Medicine

• Ētahi atu kaituhi: Ragino, Yuliya I. (Editor)
• Hōputu: Tāhiko Wāhanga pukapuka
• Reo: Ingarihi
• I whakaputaina: Basel MDPI - Multidisciplinary Digital Publishing Institute 2022
• Ngā marau: Medicine; Cardiovascular medicine; metalloproteinases; calcification; atherosclerosis; multiplex assay; coronary heart disease; aspirin; resistance; non-sensitivity; antiplatelet; light transmission aggregometry; Plateletworks®; familial hypercholesterolemia; targeted sequencing technologies; multiplex ligation-dependent probe amplification; LDLR; APOB; ABCG5; APOC3; LPL; SREBF1; rare variants; coronary atherosclerosis; ischemic heart disease; saturated fatty acids; monounsaturated fatty acids; polyunsaturated fatty acids; oxidative stress; superoxide dismutase; catalase; glutathione peroxidase; cumulative LDL-C level; prognosis; DNA methylation; epigenetic age; myocardial infarction; acute coronary syndrome; population; nested case-control; HAPIEE project; HAPIEE study; atrial fibrillation; arterial hypertension; obesity; diabetes mellitus; aging; determinants; prevalence; Russian population cohort; Cox regression analysis; adiponectin; leptin; interleukin-6; epicardial adipose tissue; perivascular adipose tissue; circulating biochemical markers; coronary atherosclerosis presence and severity; integrated biomarker (i-BIO); validation; visual markers; lipoprotein(a); immune cells blood count; n/a
• Urunga tuihono: DOAB: download the publication; DOAB: description of the publication

The first national conference with international participation, "Fundamental aspects of atherosclerosis: scientific research for improving the technologies of personalized medicine", was held in Novosibirsk on 15 October, 2021. The purpose of this conference was to disseminate the latest b...